submandibular gland peptide T
protects against endotoxic and anaphylactic shock
Also Known As:
SGP-T peptide; TDIFEGG heptapeptide; Thr-Asp-Ile-Phe-Glu-Gly-Gly
Networked: 6
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Experts
Related Diseases
1. | Anaphylaxis (Anaphylactic Shock)
11/01/1997
- " Submandibular gland peptide-T (SGP-T) inhibits intestinal anaphylaxis." 01/01/1997
- " Reduction in cardiovascular anaphylaxis by submandibular gland peptide-T." 01/01/1998
- " The effects of the submandibular gland peptide-T (SGP-T; Thr-Asp-Ile-Phe-Gly-Gly; TDIFEGG), its carboxy-terminal fragment (the tripeptide FEG; Phe-Glu-Gly), and the D-isomeric analog (feG) on intestinal and cardiovascular anaphylactic reactions were studied. " 11/01/1997
- " A novel peptide, submandibular gland peptide-T (SGP-T), which reduces allergen-induced hypotension, was examined for effects on intestinal anaphylaxis. " 12/01/2001
- " Because rat submandibular gland peptide T (SGP-T; Thr-Asp-Ile-Phe-Glu-Gly-Gly), its carboxyl-terminal fragment tripeptide, FEG (Phe-Glu-Gly) and its D-isomeric analogue, feG, modulate intestinal anaphylactic reactions, we examined whether these peptides also modulate LPS-induced intestinal endotoxaemia in conscious rats. "
|
2. | Hypotension (Low Blood Pressure)
|
3. | Fever (Fevers)
|
|
Related Drugs and Biologics
Related Therapies and Procedures